Lite Strategy

Clinical-stage pharmaceutical company(NASDAQ: LITS)

Tentang Lite Strategy

Didirikan2018
Lite Strategy, Inc.(NASDAQ: LITS) is a clinical-stage pharmaceutical company headquartered in San Diego, California, USA, focused on developing innovative therapies that primarily combat drug resistance mechanisms in cancer, aiming to improve patient outcomes in combination with standard treatments.
Komunitas
Twitter
Website
Tag
Publicly listed company
Crypto Stocks

Tren Perubahan Hot Indeks

Detail penggalangan dana

Post-IPO(2025-07-21)
JumlahRp1,70T
Penilaian--